Pharma Market Access 2015

Asia’s pharma markets is extremely complex with each country governed by very different healthcare policies, reimbursement schemes, unique pricing, and often large risks involved in entering the market, particularly with high priced, specialty drugs/therapeutics. IBC’s Pharma Market Access conference focuses on profitable market entry strategies for Asia’s diverse markets, examining reimbursement, prescribing and purchasing/procurement regulations in each market. A review of healthcare economics, policies, different business models, and an understanding of the dynamics of each market will accessed. This event is a single platform convening pharma and industry experts to navigate the complex environments and lessons learnt from successfully and profitable market entries for orphan drugs, high priced therapeutics, generics, biosimilars and more.